Bhavani Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.45 M
- Company Age 49 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.52 Cr
- Revenue Growth 14.45%
- Profit Growth 9.19%
- Ebitda 23.01%
- Net Worth 16.77%
- Total Assets 2.56%
About Bhavani Pharmaceuticals
Bhavani Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 August 1975 and has a history of 49 years and six months. Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹1.52 Cr.
Virendra Kumar and Sharad Gupta serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110UP1975PTC004154
-
Company No.
004154
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Aug 1975
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Bhavani Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Kumar
|
Managing Director | 04-Aug-1975 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sharad Gupta
|
Director | 28-Aug-2017 | Current |
Financial Performance of Bhavani Pharmaceuticals.
Bhavani Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.45% increase. The company also saw a slight improvement in profitability, with a 9.19% increase in profit. The company's net worth Soared by an impressive increase of 16.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavani Pharmaceuticals?
In 2023, Bhavani Pharmaceuticals had a public holding of 35.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹15.22 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 1.00 Cr
- Sidbi : 0.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2024 | Yes Bank Limited | ₹9.95 M | Open |
| 01 Feb 2024 | Sidbi | ₹5.27 M | Open |
How Many Employees Work at Bhavani Pharmaceuticals?
Bhavani Pharmaceuticals has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavani Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavani Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
